Autres langues Celgene

Actions

CELG

Temps Différé Nasdaq 22:00:00 20/11/2019			Varia. 5j.	Varia. 1 janv.
108,24 ^USD	+0,10%		-1,97%	+68,89%

14/06/23	Sutro Biopharma, Inc. reçoit un avis de résiliation de Celgene Corporation	CI
22/12/20	Amgen signe un accord de licence avec Medicines Development for Global Health (développement de médicaments pour la santé mondiale)	MT

Autres langues

14/06/23	Sutro Biopharma, Inc. Receives a Notice of Termination from Celgene Corporation
28/02/23	BRISTOL MYERS SQUIBB CO : Other Events (form 8-K)
25/08/22	Not What The Doctor Ordered: Authorisation Application Withdrawn For Pharma Patent Settlement In Australia
29/07/22	Authorisation request for proposed settlement between pharmaceutical companies withdrawn
24/02/22	BRISTOL MYERS SQUIBB CO : Other Events (form 8-K)
08/09/21	Biocon Limited, Biocon Pharma Limited and Biocon Pharma Inc. Enters into A Confidential Settlement Agreement with Celgene Corporation
04/08/21	Celgene : Sun Pharma And Celegene Settle Patent Dispute Over Lenalidomide (Revlimid®)
09/07/21	Besra Gold Inc: Announces Lodgment of Replacement Prospectus & Adjournment of Note Holder Meeting
22/06/21	Celgene Corporation Will Grant Sun Pharmaceutical Industries Limited A License to Celgene's Patents Required to Manufacture and Sell Certain Limited Quantity
14/04/21	Celgene : Rocket docket pharma patent litigation taking off in Australia and other emerging trends
07/04/21	DGAP-WpÜG: Angebot zum Erwerb / Zielgesellschaft: ; Bieter: qqqqq
07/04/21	DGAP-WpÜG: Tender Offer / Target company: ; Bidder: qqqqq
25/03/21	Cadila Healthcare Limited : - Zydus Announces Settlement of Patent Litigation for Generic Revlimid in U.S.
25/03/21	Leonteq wird neue Emittentin an der BX Swiss AG im Segment «deriBX»
25/03/21	Leonteq becomes new issuer on BX Swiss – “deriBX”
23/02/21	BRISTOL MYERS SQUIBB CO : Other Events (form 8-K)
23/02/21	Bristol Myers Squibb : and Celgene Issue Notices of Redemption and Partial Redemption of Certain of Their Senior Notes at 'Make Whole' Prices
23/02/21	Celgene Corporation Issues Notice of Redemption of Notes
04/02/21	Bristol-Myers Squibb Company and Celgene Corporation Announce Tender Offers for an Aggregate Purchase Price of Up to $4.0 Billion
02/02/21	BX Swiss AG startet Handel in neuem Bondsegment
05/01/21	Ikena Oncology, Inc. announced that it has received $120 million in funding from a group of investors
22/12/20	Amgen : Signs Licensing Agreement With Medicines Development for Global Health
05/11/20	Bristol Myers Squibb : Q3 Results Beat Estimates; Raises 2020 EPS Outlook
23/09/20	Silverback Therapeutics, Inc. announced that it has received $84.999996 million in funding from a group of investors
22/09/20	Silverback Therapeutics, Inc. announced that it expects to receive $84.999996 million in funding from a group of investors